Johana Castro Wagner, MD
Pediatric Allergy/Immunology · Largo, FLNPI 1003175126
Payments from drug & device makers
Across 620 payments — averaging $24.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Sanofi$2K
- CSL Behring$2K
- GSK$1K
- Takeda Pharmaceuticals U.S.A., Inc.$1K
- Regeneron Healthcare Solutions, Inc.$1K
- plus $6K from 29 others
What the payments were for
- Consulting fees$1,1207%
- Food & beverage$13,45688%
- Education$7305%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 86 | $1,912 |
| Sanofi | 64 | $1,884 |
| CSL Behring | 62 | $1,503 |
| GSK | 78 | $1,408 |
| Takeda Pharmaceuticals U.S.A., Inc. | 79 | $1,374 |
| Regeneron Healthcare Solutions, Inc. | 43 | $1,318 |
| Cycle Pharmaceuticals Inc | 3 | $1,168 |
| Novartis | 27 | $631 |
| Amgen | 24 | $524 |
| Pfizer | 29 | $450 |
| Genentech USA, Inc. | 17 | $420 |
| Biocryst US Sales Co., LLC | 14 | $388 |
| Optinose US, Inc. | 17 | $358 |
| Blueprint Medicines Corporation | 7 | $271 |
| Sanofi-aventis U.S. LLC | 3 | $256 |
| Incyte Corporation | 6 | $204 |
| Octapharma USA, Inc. | 6 | $173 |
| Kaleo, Inc. | 9 | $152 |
| Teva Pharmaceuticals USA, Inc. | 6 | $142 |
| Boehringer Ingelheim | 5 | $100 |
| Grifols USA, LLC | 4 | $93 |
| Alk-abello, Inc | 5 | $91 |
| Pharming Healthcare, Inc. | 6 | $88 |
| Shire North American Group Inc | 4 | $83 |
| Aimmune Therapeutics, Inc. | 3 | $59 |
| Greer Laboratories, Inc. | 2 | $47 |
| Insmed, Inc. | 2 | $43 |
| Covis Pharma GmbH | 2 | $39 |
| Galderma Laboratories, L.p. | 1 | $24 |
| Lilly USA, LLC | 1 | $22 |
| Kedrion Biopharma, Inc. | 1 | $20 |
| Ionis Pharmaceuticals, Inc. | 1 | $17 |
| ADMA Biomanufacturing LLC | 1 | $17 |
| Hikma Pharmaceuticals USA | 1 | $15 |
| Organon | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$15,307 in reported general payments places this provider in the 75th percentile of 30 pediatric allergy/immunology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 43 | $30,521 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 14 | $8,923 |
| Advair HfaFluticasone Propion/Salmeterol | 15 | $4,576 |
| Breo ElliptaFluticasone/Vilanterol | 11 | $4,409 |
| Epinephrine | 18 | $2,386 |
| Azelastine Hcl | 32 | $714 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 34 | $688 |
| Fluticasone Propionate | 42 | $615 |
| Ipratropium Bromide | 13 | $367 |
| Levocetirizine Dihydrochloride | 13 | $84 |
| Montelukast Sodium | 14 | $62 |
| Prednisone | 15 | $26 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta | $1,408 | $34,93054 claims |
| AstraZenecaBreztri Aerosphere | $1,912 | $8,92314 claims |
| Hikma Pharmaceuticals USAEpinephrine | $15 | $2,38618 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 30 pediatric allergy/immunology providers in Florida.
Other pediatric allergy/immunology in Largo
- Jolan WalterSt Petersburg$1.1M
- Jennifer LeidingOrlando$350K
- Panida SriaroonSaint Petersburg$344K
- Mark BallowTampa$332K
- Vivian Hernandez-TrujilloMiami Lakes$285K
- Hary KatzJacksonville$67K
- Jonathan MalkaNorth Miami Beach$32K
- Diana MartinTampa$12K
- Sharon LeonardJacksonville$8K
- Ilene GoldsteinBoynton Beach$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.